The introduction of electronic cigarettes (e-cigarettes) in recent years has created new dilemmas for clinical and research communities. E-cigarettes are battery-powered devices that heat liquids containing nicotine, flavoring, and other substances to create aerosols. Their use is often called "vaping." E-cigarettes have been marketed as safer alternatives to cigarettes because they do not contain the carcinogens found in combustible tobacco products. More than 4.5% of US adults, 10% of high school students, and 4.6% of middle school students report currently using e-cigarettes. 1,2 The dilemmas from e-cigarettes arise from their contrasting benefits and risks. They may help current smokers quit conventional cigarettes, but their long-term effects are unknown, and they may serve as an entry point to nicotine addiction for nonsmokers, particularly adolescents. For adult smokers, a recent Cochrane review found high certainty that e-cigarettes produce higher quit rates than nicotine replacement therapy. 3 However, the substitution of e-cigarettes as an aid to smoking cessation may lead to long-term use of the e-cigarettes themselves. For nonsmokers, e-cigarettes hold no benefits, and they may increase the risk of nicotine addiction for adolescents, in part because they are more appealing and easily concealed than cigarettes.To elucidate this evolving topic, JAMA presents a cluster of articles on e-cigarette use and cessation interventions, including a Patient Page, Original Investigation and related Editorial, 2 clinical Insights (focused on e-cigarette use in adolescents and in adults), a JAMA Revisited historical reprint, Research Letter, and Medical News article.The Patient Page by Malani and Walter 4 provides a highly accessible and cogent overview of e-cigarettes and their potential health risks as well as potential benefit for current smokers.